Sintx Technologies (NASDAQ:SINT) & Cooper Companies (NASDAQ:COO) Head-To-Head Contrast

Cooper Companies (NASDAQ:COO) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk and valuation.

Valuation & Earnings

This table compares Cooper Companies and Sintx Technologies”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09 billion	2.50	$374.90 million	$2.93	18.40
Sintx Technologies	$1.02 million	7.62	-$10.36 million	($4.91)	-0.37

Cooper Companies has higher revenue and earnings than Sintx Technologies. Sintx Technologies is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Cooper Companies and Sintx Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cooper Companies	13.46%	10.90%	7.24%
Sintx Technologies	-848.20%	-354.44%	-115.37%

Institutional & Insider Ownership

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 4.1% of Sintx Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Cooper Companies and Sintx Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	2	11	5	0	2.17
Sintx Technologies	1	0	3	0	2.50

Cooper Companies currently has a consensus target price of $71.47, suggesting a potential upside of 32.57%. Sintx Technologies has a consensus target price of $9.33, suggesting a potential upside of 418.52%. Given Sintx Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Sintx Technologies is more favorable than Cooper Companies.

Summary

Cooper Companies beats Sintx Technologies on 9 of the 13 factors compared between the two stocks.

About Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.